Biden administration sets out plan to reduce price of 10 drugs used by over 65s that cost $50bn a year
BMJ 2023; 382 doi: https://doi.org/10.1136/bmj.p2022 (Published 01 September 2023) Cite this as: BMJ 2023;382:p2022- Janice Hopkins Tanne
- New York
President Joe Biden’s administration has announced it will begin negotiating prices for 10 expensive drugs used by people who are covered by the Medicare health insurance scheme for over 65s.1
US drug prices are among the highest in the world, but negotiating prices was forbidden until passage of the Inflation Reduction Act last year.
Biden said, “For far too long Americans have paid more for prescription drugs than any major economy. And while the pharmaceutical industry makes record profits, millions of Americans are forced to choose between paying for medications they need to live or paying for food, rent, and other basic necessities . . . There is no reason why Americans should be forced to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.